MA56107A - Compositions comprenant une souche bactérienne lactobacillus paracasei et de l'acide hyaluronique et leur utilisation dans le traitement de la peau - Google Patents

Compositions comprenant une souche bactérienne lactobacillus paracasei et de l'acide hyaluronique et leur utilisation dans le traitement de la peau

Info

Publication number: MA56107A
Authority: MA; Morocco
Prior art keywords: skin; compositions; treatment; hyaluronic acid; bacterial strain
Prior art date: 2019-06-05

Application number

MA056107A

Other languages

English (en)

Inventor

Andrea Biffi

Original Assignee

Lac2Biome S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-06-05

Filing date

2020-06-05

Publication date

2022-04-13

2020-06-05 Application filed by Lac2Biome S R L filed Critical Lac2Biome S R L

2022-04-13 Publication of MA56107A publication Critical patent/MA56107A/fr

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
241000186605 Lactobacillus paracasei Species 0.000 title 1
230000001580 bacterial effect Effects 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Birds (AREA)
Gerontology & Geriatric Medicine (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Rheumatology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA056107A 2019-06-05 2020-06-05 Compositions comprenant une souche bactérienne lactobacillus paracasei et de l'acide hyaluronique et leur utilisation dans le traitement de la peau MA56107A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT201900008097		2019-06-05

Publications (1)

Publication Number	Publication Date
MA56107A true MA56107A (fr)	2022-04-13

Family

ID=68073033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA056107A MA56107A (fr)	2019-06-05	2020-06-05	Compositions comprenant une souche bactérienne lactobacillus paracasei et de l'acide hyaluronique et leur utilisation dans le traitement de la peau

Country Status (15)

Country	Link
US (1)	US20220313757A1 (fr)
EP (1)	EP3979982B1 (fr)
JP (2)	JP7680376B2 (fr)
KR (1)	KR102915719B1 (fr)
CN (1)	CN114025778B (fr)
AU (1)	AU2020287268B2 (fr)
BR (1)	BR112021023340A2 (fr)
CA (1)	CA3142566A1 (fr)
DK (1)	DK3979982T3 (fr)
ES (1)	ES2947484T3 (fr)
MA (1)	MA56107A (fr)
MX (1)	MX2021014633A (fr)
PL (1)	PL3979982T3 (fr)
WO (1)	WO2020245797A1 (fr)
ZA (1)	ZA202109421B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112870148B (zh) *	2021-01-18	2023-04-07	广东轻工职业技术学院	一种基于牵引结构的微生态平衡的益生素微球的制备方法
WO2022157307A1 (fr) *	2021-01-22	2022-07-28	Dsm Ip Assets B.V.	Acide hyaluronique en tant qu'agent antimicrobien destiné à être utilisé sur la peau
CN112940968B (zh) *	2021-02-07	2022-07-01	山东凤凰生物科技股份有限公司	一种发酵乳杆菌、发酵乳杆菌的培养物及其制备方法
JP7594980B2 (ja) *	2021-06-22	2024-12-05	株式会社ヤクルト本社	単純ヘルペスウイルスの再活性化抑制用組成物
IT202100017855A1 (it) *	2021-07-06	2023-01-06	Lac2Biome S R L	Bacteria strains for topical skin care
CN114703079B (zh) *	2021-09-08	2023-05-26	青岛蔚蓝生物股份有限公司	一株副干酪乳杆菌及其在缓解皮肤损伤中的应用
JP2024543178A (ja) *	2021-11-30	2024-11-19	インターナショナルエヌアンドエイチデンマークエーピーエス	皮膚老化用のラクトバチルス（ｌａｃｔｏｂａｃｉｌｌｉ）
KR102739246B1 (ko) *	2022-02-11	2024-12-06	주식회사 잇츠한불	락토바실러스 균주 혼합물을 유효성분으로 포함하는 피부 보호용 조성물
CN116762959B (zh) *	2022-03-11	2025-04-18	青岛蔚蓝生物股份有限公司	一种副干酪乳酪杆菌微胶囊及其制备方法和应用
IT202200014323A1 (it) *	2022-07-06	2024-01-06	Lac2Biome S R L	Ceppi di batteri per la cura topica della pelle
CN115044519B (zh) *	2022-08-12	2022-10-25	山东锦鲤生物工程有限公司	解淀粉乳杆菌及其应用
KR102485314B1 (ko) *	2022-09-22	2023-01-09	주식회사 에이바이오머티리얼즈	유산균 발효 시어버터와 유산균 발효 시어버터 배양액 유래 엑소좀의 복합물을 유효성분으로 함유하는 화장료 조성물
US20240245746A1 (en) *	2023-01-19	2024-07-25	Tci Co., Ltd.	Method for regulating immunity by using black hulless barley extract
CN117625454B (zh) *	2023-11-22	2026-02-27	江南大学	一株有抗糖化抗衰功能的副干酪乳酪杆菌ccfm1355及其后生元
CN117721036A (zh) *	2023-11-22	2024-03-19	江南大学	一株调控Wnt/β-catenin通路防脱的副干酪乳酪杆菌CCFM1350及其后生元
WO2025128710A2 (fr) *	2023-12-11	2025-06-19	University Of South Florida	Souches bactériennes destinées à la santé de la peau
EP4635475A1 (fr) *	2024-04-15	2025-10-22	CLR-Chemisches Laboratorium Dr. Kurt Richter GmbH	Composition cosmétique comprenant des composants bactériens
EP4722390A1 (fr) *	2024-10-04	2026-04-08	Laboratoires M & L	Bacterie du genre brevundimonas et ses utilisations cosmetiques
KR102851445B1 (ko) *	2024-12-27	2025-08-28	(주)에이스바이옴	락티카제이바실러스 파라카제이 아종 파라카제이 abf21013를 포함하는 피부노화 예방 또는 개선용 조성물
CN119842565B (zh) *	2025-03-18	2025-08-22	东北农业大学	一株副干酪乳杆菌及其在抗衰老和抗糖化中的应用
KR102866782B1 (ko) *	2025-07-31	2025-10-01	주식회사 일진코스메틱	버섯 5종 추출 배양액을 포함하는 자생력 증진, 보습, 미백 및 항산화용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0517363A (ja) *	1991-07-11	1993-01-26	Yakult Honsha Co Ltd	抗炎症剤及びそれを含有する化粧料
JP4010574B2 (ja) *	1994-12-05	2007-11-21	電気化学工業株式会社	皮膚外用剤
KR101449687B1 (ko) *	2008-03-13	2014-10-14	주식회사 바이오랜드	저분자 및 고분자 히알루론산과 유근피로부터 분리된다당체 추출물을 함유하는 노화방지용 조성물
JP2010173991A (ja) *	2009-01-30	2010-08-12	Kouai Kagaku Co Ltd	皮膚外用剤
FR2942719B1 (fr) *	2009-03-04	2011-08-19	Oreal	Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
KR20140127437A (ko) *	2013-04-24	2014-11-04	학교법인연세대학교	락토바실러스 파라카제이 ｍｋ１을 이용한 주름개선용 화장료 조성물 및 그 제조방법
KR20150087634A (ko)	2014-01-22	2015-07-30	주식회사한국야쿠르트	여드름 원인균 프로피오니박테리움 아크네스의 생장억제 효능을 가지는 락토바실러스 파라카제이 hy7301 및 이를 유효성분으로 함유하는 제품
TWM483083U (zh) *	2014-03-13	2014-08-01	Shiteh Organic Pharmaceutical Co Ltd	一種乳酸菌結合有機植物萃取可用於治療與預防異位性皮膚炎、濕疹、汗疹、小兒尿布疹與青春痘等皮膚炎之雙球體微脂粒結構。
MA39710A (fr) *	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
KR20160092569A (ko) *	2015-01-27	2016-08-05	인코스(주)	효모, 유산균 2단 발효 추출물을 함유하는 항산화, 주름개선, 보습 효과를 갖는 화장료 조성물
KR101764412B1 (ko) *	2015-09-14	2017-08-14	일동바이오사이언스(주)	기능성 수화 히알루론산 및 이를 이용한 장 점막부착능이 우수하고 선택적 길항작용을 하는 코팅 유산균의 제조방법
WO2017195182A1 (fr) *	2016-05-13	2017-11-16	Sofar S.P.A.	Utilisation de probiotiques pour améliorer l'absorption des protéines
IT201600122724A1 (it) *	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
CN106902073A (zh) *	2017-01-19	2017-06-30	长沙协浩吉生物工程有限公司	一种酵素抗衰老精华液的配制方法
TW201904593A (zh) *	2017-05-23	2019-02-01	日商一丸自然美健有限公司	皮膚常居菌平衡改善劑、含有乳酸菌的化妝材料以及皮膚保護劑
IT201700101704A1 (it) *	2017-09-12	2019-03-12	Sofar Spa	Nuovo uso per trattamento delle infezioni da clostridium difficile
BR112020010930A2 (pt) *	2017-12-06	2020-11-17	Lac2biome S.r.l.	composição baseada em probióticos e usos dos mesmos

2020
- 2020-06-05 MA MA056107A patent/MA56107A/fr unknown
- 2020-06-05 JP JP2021572311A patent/JP7680376B2/ja active Active
- 2020-06-05 WO PCT/IB2020/055326 patent/WO2020245797A1/fr not_active Ceased
- 2020-06-05 MX MX2021014633A patent/MX2021014633A/es unknown
- 2020-06-05 PL PL20736427.4T patent/PL3979982T3/pl unknown
- 2020-06-05 ES ES20736427T patent/ES2947484T3/es active Active
- 2020-06-05 BR BR112021023340A patent/BR112021023340A2/pt unknown
- 2020-06-05 DK DK20736427.4T patent/DK3979982T3/da active
- 2020-06-05 EP EP20736427.4A patent/EP3979982B1/fr active Active
- 2020-06-05 CA CA3142566A patent/CA3142566A1/fr active Pending
- 2020-06-05 KR KR1020227000365A patent/KR102915719B1/ko active Active
- 2020-06-05 AU AU2020287268A patent/AU2020287268B2/en active Active
- 2020-06-05 CN CN202080041816.2A patent/CN114025778B/zh active Active
- 2020-06-05 US US17/616,589 patent/US20220313757A1/en active Pending
2021
- 2021-11-23 ZA ZA2021/09421A patent/ZA202109421B/en unknown
2025
- 2025-05-08 JP JP2025077774A patent/JP2025121990A/ja active Pending

Also Published As

Publication number	Publication date
CN114025778A (zh)	2022-02-08
JP2025121990A (ja)	2025-08-20
BR112021023340A2 (pt)	2022-04-12
MX2021014633A (es)	2022-02-11
CA3142566A1 (fr)	2020-12-10
US20220313757A1 (en)	2022-10-06
JP7680376B2 (ja)	2025-05-20
AU2020287268A1 (en)	2022-01-06
AU2020287268B2 (en)	2026-02-19
DK3979982T3 (da)	2023-07-03
WO2020245797A1 (fr)	2020-12-10
JP2022535875A (ja)	2022-08-10
ZA202109421B (en)	2023-06-28
PL3979982T3 (pl)	2023-08-07
EP3979982A1 (fr)	2022-04-13
KR102915719B1 (ko)	2026-01-20
EP3979982B1 (fr)	2023-04-05
ES2947484T3 (es)	2023-08-10
CN114025778B (zh)	2024-04-12
KR20220016983A (ko)	2022-02-10

Publication	Publication Date	Title
MA56107A (fr)	2022-04-13	Compositions comprenant une souche bactérienne lactobacillus paracasei et de l'acide hyaluronique et leur utilisation dans le traitement de la peau
EP3755805A4 (fr)	2022-01-19	Compositions et méthodes de traitement d'une hypoacousie non associée à l'âge chez un sujet humain
EP3858977A4 (fr)	2022-06-01	Souche pour la prévention et le traitement de maladies métaboliques et utilisation associée
EP4252554A4 (fr)	2024-10-23	Utilisation de lactobacillus paracasei et-22 dans l'amélioration de la résistance à l'infection bactérienne intestinale et de l'immunité intestinale
MA56040A (fr)	2022-04-06	Compositions comprenant des acides gras cétylés et leur utilisation dans le traitement de l'arthrite et des états inflammatoires articulaires
EP4364745A3 (fr)	2024-07-17	Nouvelles bactéries lactiques et leur utilisation
MA43488A1 (fr)	2019-12-31	Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis
EP4243796A4 (fr)	2025-01-22	Utilisation améliorée de cannabinoïdes dans le traitement de l'épilepsie
EP2185202A4 (fr)	2013-11-06	Utilisation de l'interleukine-22 dans le traitement de la stéatose hépatique
EP4076444A4 (fr)	2024-01-10	Dérivés d'indazole et leurs méthodes d'utilisation dans le traitement de l'herpès virus
MA52971A (fr)	2021-04-28	Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
MA49794A (fr)	2020-06-03	Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire
EP3630124A4 (fr)	2021-02-24	Composition synthétique comprenant des oligosaccharides et son utilisation dans un traitement médical
JP2016516985A5 (fr)	2017-04-27
EP2854910A4 (fr)	2016-02-24	Niveaux de céramide dans le traitement et la prévention d'infections
EP2906570A4 (fr)	2016-06-08	Utilisation de bases à chaînes longues sphingoïdes et de leurs analogues dans le traitement et la prévention d'infections bactériennes
WO2019098810A3 (fr)	2019-07-18	Nouvelles bactéries lactiques et leur utilisation
EP3302464A4 (fr)	2019-01-23	Utilisation de cannabinoïdes dans le traitement de l'inflammation et/ou de la douleur oculaire
EP3883618C0 (fr)	2023-08-02	Composition injectable comprenant de l'acide hyaluronique et utilisation de ladite composition
EP2258374A4 (fr)	2012-07-25	Utilisation de l'acide maslinique dans le traitement de pathologies et de leurs symptômes par inhibition de cox-2
EP2608783A4 (fr)	2014-03-05	Utilisation d'acide glycyrrhétinique, d'acide glycyrrhizique et de composés associés pour prévention et/ou traitement de fibrose pulmonaire
EP3534908A4 (fr)	2020-05-27	Composés de 9-aminométhylminocycline et leur utilisation dans le traitement de la pneumonie bactérienne d'acquisition communautaire (cabp)
MA49635A (fr)	2020-05-27	Compositions comprenant du darunavir, du cobicistat, de l'emtricitabine et du ténofovir alafénamide pour une utilisation dans le traitement du vih
EP3634391A4 (fr)	2021-02-24	Utilisation de formulations de coenzyme q10 dans le traitement et la prévention de l'épidermolyse bulleuse
FR2999932B1 (fr)	2020-01-31	Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine